Jaw-Town Lin - Search Results

Year	Number of Results
2001	1
2002	18
2003	13
2004	16
2005	19
2006	35
2007	24
2008	22
2009	19
2010	17
2011	18
2012	24
2013	22
2014	18
2015	18
2016	21
2017	21
2018	21
2019	9
2020	10
2021	9
2022	14
2023	9
2024	6

1

Administration of oral prednisolone to prevent esophageal stricture after balloon-type radiofrequency ablation for ultralong-segment esophageal neoplasia.

Wang WL, Tsai YN, Hsu MH, Lin JT, Wang HP, Lee CT. Wang WL, et al. Among authors: lin jt. Gastrointest Endosc. 2024 Apr 5:S0016-5107(24)00212-8. doi: 10.1016/j.gie.2024.03.030. Online ahead of print. Gastrointest Endosc. 2024. PMID: 38583540

2

Prognostic significances of systemic inflammatory response markers in patients with synchronous esophageal and head and neck cancers.

Wang CC, Hsu MH, Lee CT, Chen CJ, Hwang TZ, Wang HP, Lin JT, Wang WL. Wang CC, et al. Among authors: lin jt. Head Neck. 2024 Feb 12. doi: 10.1002/hed.27677. Online ahead of print. Head Neck. 2024. PMID: 38344911

3

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy.

Huang YK, Cheng WC, Kuo TT, Yang JC, Wu YC, Wu HH, Lo CC, Hsieh CY, Wong SC, Lu CH, Wu WL, Liu SJ, Li YC, Lin CC, Shen CN, Hung MC, Lin JT, Yeh CC, Sher YP. Huang YK, et al. Among authors: lin jt. Nat Cancer. 2024 Mar;5(3):400-419. doi: 10.1038/s43018-023-00720-x. Epub 2024 Jan 24. Nat Cancer. 2024. PMID: 38267627

4

Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022.

Chen YC, Malfertheiner P, Yu HT, Kuo CL, Chang YY, Meng FT, Wu YX, Hsiao JL, Chen MJ, Lin KP, Wu CY, Lin JT, O'Morain C, Megraud F, Lee WC, El-Omar EM, Wu MS, Liou JM. Chen YC, et al. Among authors: lin jt. Gastroenterology. 2024 Apr;166(4):605-619. doi: 10.1053/j.gastro.2023.12.022. Epub 2024 Jan 2. Gastroenterology. 2024. PMID: 38176660

5

Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation.

Tsai YN, Wu JL, Tseng CH, Chen TH, Wu YL, Chen CC, Fang YJ, Yang TH, Nguyen MH, Lin JT, Hsu YC. Tsai YN, et al. Among authors: lin jt. Clin Mol Hepatol. 2024 Jan;30(1):98-108. doi: 10.3350/cmh.2023.0194. Epub 2023 Dec 14. Clin Mol Hepatol. 2024. PMID: 38092551 Free PMC article.

6

Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis.

Hong TC, El-Omar EM, Kuo YT, Wu JY, Chen MJ, Chen CC, Fang YJ, Leow AHR, Lu H, Lin JT, Tu YK, Yamaoka Y, Wu MS, Liou JM; Asian Pacific Alliance on Helicobacter and Microbiota. Hong TC, et al. Among authors: lin jt. Lancet Gastroenterol Hepatol. 2024 Jan;9(1):56-67. doi: 10.1016/S2468-1253(23)00281-9. Epub 2023 Nov 14. Lancet Gastroenterol Hepatol. 2024. PMID: 37972625

7

Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study.

Lee TY, Hsu YC, Ho HJ, Lin JT, Chen YJ, Wu CY. Lee TY, et al. Among authors: lin jt. EClinicalMedicine. 2023 Jun 29;61:102065. doi: 10.1016/j.eclinm.2023.102065. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37434747 Free PMC article.

8

Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population-based cohort study.

Hsu YC, Lin YH, Lee TY, Nguyen MH, Tseng CH, Ho HJ, Kao FY, Lin JT, Wu CY, Wu CY. Hsu YC, et al. Among authors: lin jt. Aliment Pharmacol Ther. 2023 Aug;58(4):463-473. doi: 10.1111/apt.17614. Epub 2023 Jun 21. Aliment Pharmacol Ther. 2023. PMID: 37341016

9

Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing.

Chung AK, Lin RT, Yeh CC, Yang CY, Wu CJ, Chen PL, Lin JT. Chung AK, et al. Among authors: lin jt. Front Genet. 2023 May 10;14:1172365. doi: 10.3389/fgene.2023.1172365. eCollection 2023. Front Genet. 2023. PMID: 37234870 Free PMC article.

10

Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.

Chen MJ, Chen PY, Fang YJ, Bair MJ, Chen CC, Chen CC, Yang TH, Lee JY, Yu CC, Kuo CC, Chiu MC, Chou CK, Chen CY, Hu WH, Tsai MH, Hsu YC, Shun CT, Luo JC, Lin JT, El-Omar EM, Wu MS, Liou JM; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Chen MJ, et al. Among authors: lin jt. Lancet Gastroenterol Hepatol. 2023 Jul;8(7):623-634. doi: 10.1016/S2468-1253(23)00097-3. Epub 2023 May 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37178702 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

348 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Results by year